<SEC-DOCUMENT>0001209191-21-008244-index.html : 20210205
<SEC-HEADER>0001209191-21-008244.hdr.sgml : 20210205
<ACCEPTANCE-DATETIME>20210205175957
ACCESSION NUMBER:		0001209191-21-008244
CONFORMED SUBMISSION TYPE:	5
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210205
DATE AS OF CHANGE:		20210205

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Galante Joseph C
		CENTRAL INDEX KEY:			0001632384

	FILING VALUES:
		FORM TYPE:		5
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		21597633

	MAIL ADDRESS:	
		STREET 1:		111 TENTH AVENUE
		STREET 2:		SUITE 200
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>5
<SEQUENCE>1
<FILENAME>doc5.xml
<DESCRIPTION>FORM 5 SUBMISSION
<TEXT>
Document 1 - file: doc5.html

Document 1 - RAW XML: doc5.xml

</DOCUMENT>
</SEC-DOCUMENT>